TNFRSF11B and bone neoplasm: In recent years, molecular biology studies have shown that mutations of tumor suppressor gene p53, Receptor activator of nuclear factor-κΒ ligand (RANKL), osteoprotegerin, and other genes may be related to the pathogenesis of bone tumors (12).